| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 8, 577-584, Copyright © 1994 by Endocrine Society
ARTICLES |
Y Zhang, W Bai, VE Allgood and NL Weigel
Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030.
We have previously reported that treatment of CV1 cells, transiently transfected with DNA encoding the chicken progesterone receptor (cPR) and a reporter plasmid PREtkCAT, with either 8-Br-cAMP or okadaic acid resulted in ligand-independent transcriptional activation of the cPR. The surprising finding that cPR can be activated in the absence of hormone has been followed by numerous studies from other laboratories examining the effects of modulators of kinases and phosphatases on the activity of other steroid receptors. These studies have yielded mixed results: ligand-independent activation has been observed in some cases, but not in others. In order to determine whether the ligand-independent activation of cPR was restricted to a specific reporter and cell type and to better characterize this phenomenon, the studies in this report were undertaken. Using both the original reporter, PREtkCAT, and a simpler reporter, GRE2E1bCAT, we found that ligand-independent activation of the cPR can be induced in both CV1 and HeLa cells. The magnitude of the response and the response of the reporter alone differed in the two cell types. Further analysis of the activation of cPR by inhibitors of protein phosphatases showed that inhibition of phosphatase 1 rather than phosphatase 2A was necessary for activation of cPR. Finally, treatment with vanadate, an inhibitor of phosphotyrosine phosphatases, or epidermal growth factor resulted in activation of cPR. These studies suggest that signals transduced through multiple signaling pathways can activate cPR.
This article has been cited by other articles:
![]() |
A. Gordon, J. C Garrido-Gracia, R. Aguilar, S. Guil-Luna, Y. Millan, J. M. de las Mulas, and J. E Sanchez-Criado Ovarian stimulation with FSH reduces phosphorylation of gonadotrope progesterone receptor and LH secretion in the rat Reproduction, January 1, 2009; 137(1): 151 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gordon, J. C Garrido-Gracia, R. Aguilar, C. Bellido, J. A G. Velasco, Y. Millan, M. Tena-Sempere, J. Martin de las Mulas, and J. E Sanchez-Criado The ovary-mediated FSH attenuation of the LH surge in the rat involves a decreased gonadotroph progesterone receptor (PR) action but not PR expression J. Endocrinol., March 1, 2008; 196(3): 583 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Carnevale, C. J. Proietti, M. Salatino, A. Urtreger, G. Peluffo, D. P. Edwards, V. Boonyaratanakornkit, E. H. Charreau, E. B. de Kier Joffe, R. Schillaci, et al. Progestin Effects on Breast Cancer Cell Proliferation, Proteases Activation, and in Vivo Development of Metastatic Phenotype All Depend on Progesterone Receptor Capacity to Activate Cytoplasmic Signaling Pathways Mol. Endocrinol., June 1, 2007; 21(6): 1335 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E Sanchez-Criado, J. C Garrido-Gracia, C. Bellido, R. Aguilar, P. Guelmes, P. Abreu, R. Alonso, I. Barranco, Y. Millan, and J. M. de las Mulas Oestradiol-17{beta} inhibits tamoxifen-induced LHRH self-priming blocking hormone-dependent and ligand-independent activation of the gonadotrope progesterone receptor in the rat. J. Endocrinol., July 1, 2006; 190(1): 73 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Mani, A. M. Reyna, J. Z. Chen, B. Mulac-Jericevic, and O. M. Conneely Differential Response of Progesterone Receptor Isoforms in Hormone-Dependent and -Independent Facilitation of Female Sexual Receptivity Mol. Endocrinol., June 1, 2006; 20(6): 1322 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Proia, B. W. Nannenga, L. A. Donehower, and N. L. Weigel Dual Roles for the Phosphatase PPM1D in Regulating Progesterone Receptor Function J. Biol. Chem., March 17, 2006; 281(11): 7089 - 7101. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Narayanan, D. P. Edwards, and N. L. Weigel Human Progesterone Receptor Displays Cell Cycle-Dependent Changes in Transcriptional Activity Mol. Cell. Biol., April 15, 2005; 25(8): 2885 - 2898. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Jacobsen, S. A. Schittone, J. K. Richer, and K. B. Horwitz Progesterone-Independent Effects of Human Progesterone Receptors (PRs) in Estrogen Receptor-Positive Breast Cancer: PR Isoform-Specific Gene Regulation and Tumor Biology Mol. Endocrinol., March 1, 2005; 19(3): 574 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Narayanan, A. A. Adigun, D. P. Edwards, and N. L. Weigel Cyclin-Dependent Kinase Activity Is Required for Progesterone Receptor Function: Novel Role for Cyclin A/Cdk2 as a Progesterone Receptor Coactivator Mol. Cell. Biol., January 1, 2005; 25(1): 264 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. U. Agoulnik, X.-W. Tong, D.-C. Fischer, K. Korner, N. E. Atkinson, D. P. Edwards, D. R. Headon, N. L. Weigel, and D. G. Kieback A Germline Variation in the Progesterone Receptor Gene Increases Transcriptional Activity and May Modify Ovarian Cancer Risk J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6340 - 6347. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Narayanan, V. A. T. Sepulveda, M. Falzon, and N. L. Weigel The Functional Consequences of Cross-talk between the Vitamin D Receptor and ERK Signaling Pathways Are Cell-specific J. Biol. Chem., November 5, 2004; 279(45): 47298 - 47310. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li and B. W. O'Malley Unfolding the Action of Progesterone Receptors J. Biol. Chem., October 10, 2003; 278(41): 39261 - 39264. [Full Text] [PDF] |
||||
![]() |
I. U. Agoulnik, W. C. Krause, W. E. Bingman III, H. T. Rahman, M. Amrikachi, G. E. Ayala, and N. L. Weigel Repressors of Androgen and Progesterone Receptor Action J. Biol. Chem., August 15, 2003; 278(33): 31136 - 31148. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Lamb, E. Puxeddu, N. Malik, D. L. Stenoien, R. Nigam, G. Y. Saleh, M. Mancini, N. L. Weigel, and M. Marcelli Molecular Analysis of the Androgen Receptor in Ten Prostate Cancer Specimens Obtained Before and After Androgen Ablation J Androl, March 1, 2003; 24(2): 215 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Labriola, M. Salatino, C. J. Proietti, A. Pecci, O. A. Coso, A. R. Kornblihtt, E. H. Charreau, and P. V. Elizalde Heregulin Induces Transcriptional Activation of the Progesterone Receptor by a Mechanism That Requires Functional ErbB-2 and Mitogen-Activated Protein Kinase Activation in Breast Cancer Cells Mol. Cell. Biol., February 1, 2003; 23(3): 1095 - 1111. [Abstract] [Full Text] |
||||
![]() |
A. J. James, I. U. Agoulnik, J. M. Harris, G. Buchanan, W. D. Tilley, M. Marcelli, D. J. Lamb, and N. L. Weigel A Novel Androgen Receptor Mutant, A748T, Exhibits Hormone Concentration-Dependent Defects in Nuclear Accumulation and Activity Despite Normal Hormone-Binding Affinity Mol. Endocrinol., December 1, 2002; 16(12): 2692 - 2705. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Jacobsen, J. K. Richer, S. A. Schittone, and K. B. Horwitz New Human Breast Cancer Cells to Study Progesterone Receptor Isoform Ratio Effects and Ligand-independent Gene Regulation J. Biol. Chem., July 26, 2002; 277(31): 27793 - 27800. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Smith, R. G. Wolford, T. B. ONeill, and G. L. Hager Characterization of Transiently and Constitutively Expressed Progesterone Receptors: Evidence for Two Functional States Mol. Endocrinol., July 1, 2000; 14(7): 956 - 971. [Abstract] [Full Text] |
||||
![]() |
E. M. Apostolakis, J. Garai, J. E. Lohmann, J. H. Clark, and B. W. OMalley Epidermal Growth Factor Activates Reproductive Behavior Independent of Ovarian Steroids in Female Rodents Mol. Endocrinol., July 1, 2000; 14(7): 1086 - 1098. [Abstract] [Full Text] |
||||
![]() |
P. E. Chappell and J. E. Levine Stimulation of Gonadotropin-Releasing Hormone Surges by Estrogen. I. Role of Hypothalamic Progesterone Receptors Endocrinology, April 1, 2000; 141(4): 1477 - 1485. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. Nazareth, D. L. Stenoien, W. E. Bingman III, A. J. James, C. Wu, Y. Zhang, D. P. Edwards, M. Mancini, M. Marcelli, D. J. Lamb, et al. A C619Y Mutation in the Human Androgen Receptor Causes Inactivation and Mislocalization of the Receptor with Concomitant Sequestration of SRC-1 (Steroid Receptor Coactivator 1) Mol. Endocrinol., December 1, 1999; 13(12): 2065 - 2075. [Abstract] [Full Text] |
||||
![]() |
J. Liu and D. B. DeFranco Chromatin Recycling of Glucocorticoid Receptors: Implications for Multiple Roles of Heat Shock Protein 90 Mol. Endocrinol., March 1, 1999; 13(3): 355 - 365. [Abstract] [Full Text] |
||||
![]() |
C. Massaad, N. Houard, M. Lombès, and R. Barouki Modulation of Human Mineralocorticoid Receptor Function by Protein Kinase A Mol. Endocrinol., January 1, 1999; 13(1): 57 - 65. [Abstract] [Full Text] |
||||
![]() |
S. Le Bihan, V. Marsaud, C. Mercier-Bodard, E.-E. Baulieu, S. Mader, J. H. White, and J.-M. Renoir Calcium/Calmodulin Kinase Inhibitors and Immunosuppressant Macrolides Rapamycin and FK506 Inhibit Progestin- and Glucocorticosteroid Receptor-Mediated Transcription in Human Breast Cancer T47D Cells Mol. Endocrinol., July 1, 1998; 12(7): 986 - 1001. [Abstract] [Full Text] |
||||
![]() |
E. R. de Kloet, E. Vreugdenhil, M. S. Oitzl, and M. Joëls Brain Corticosteroid Receptor Balance in Health and Disease Endocr. Rev., June 1, 1998; 19(3): 269 - 301. [Abstract] [Full Text] |
||||
![]() |
N. Xiao and D. B. DeFranco Overexpression of Unliganded Steroid Receptors Activates Endogenous Heat Shock Factor Mol. Endocrinol., August 1, 1997; 11(9): 1365 - 1374. [Abstract] [Full Text] |
||||
![]() |
Y. Zhang, C. A. Beck, A. Poletti, J. P. Clement IV, P. Prendergast, T.-T. Yip, T. W. Hutchens, D. P. Edwards, and N. L. Weigel Phosphorylation of Human Progesterone Receptor by Cyclin-Dependent Kinase 2 on Three Sites That Are Authentic Basal Phosphorylation Sites In Vivo Mol. Endocrinol., June 1, 1997; 11(6): 823 - 832. [Abstract] [Full Text] |
||||
![]() |
J. Yang, J. Liu, and D. B. DeFranco Subnuclear Trafficking of Glucocorticoid Receptors In Vitro: Chromatin Recycling and Nuclear Export J. Cell Biol., May 5, 1997; 137(3): 523 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Bai, B. G. Rowan, V. E. Allgood, B. W. O'Malley, and N. L. Weigel Differential Phosphorylation of Chicken Progesterone Receptor in Hormone-dependent and Ligand-independent Activation J. Biol. Chem., April 18, 1997; 272(16): 10457 - 10463. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. Nazareth and N. L. Weigel Activation of the Human Androgen Receptor through a Protein Kinase A Signaling Pathway J. Biol. Chem., August 16, 1996; 271(33): 19900 - 19907. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Bai and N. L. Weigel Phosphorylation of Ser211 in the Chicken Progesterone Receptor Modulates its Transcriptional Activity J. Biol. Chem., May 31, 1996; 271(22): 12801 - 12806. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-c. Hsu and D. B. DeFranco Selectivity of Cell Cycle Regulation of Glucocorticoid Receptor Function J. Biol. Chem., February 17, 1995; 270(7): 3359 - 3364. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Knotts, R. S. Orkiszewski, R. G. Cook, D. P. Edwards, and N. L. Weigel Identification of a Phosphorylation Site in the Hinge Region of the Human Progesterone Receptor and Additional Amino-terminal Phosphorylation Sites J. Biol. Chem., March 9, 2001; 276(11): 8475 - 8483. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |